Excessive activation of HCK is reported to be associated with various leukemia, such as chronic myeloid leukemia (CML), multiple myeloma, and acute lymphoblastic leukemia, as well as solid malignancies including colorectal, breast, and gastric cancer [11–13]. Here, HCK is linked to AL amyloidosis.